Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
$36.23
+0.8%
$31.34
$19.80
$37.92
$37.32MN/A42,390 shs21,371 shs
FCUS
Pinnacle Focused Opportunities ETF
$25.03
+0.7%
$22.86
$19.52
$38.02
$34.54M1.858,835 shs3,696 shs
INRO
iShares U.S. Industry Rotation Active ETF
$27.86
+0.5%
$26.01
$22.67
$29.01
$26.19M1.499,166 shs60,573 shs
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$11.15
+0.3%
$2.78
$2.10
$7.00
$26.93M1.07112,188 shs11 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
+2.86%-3.31%+12.28%+35.21%+3,593,999,900.00%
FCUS
Pinnacle Focused Opportunities ETF
+1.68%+1.89%+7.16%-4.24%-12.44%
INRO
iShares U.S. Industry Rotation Active ETF
+0.84%+2.33%+4.61%+2.74%+10.55%
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.00%+1.57%+6.19%+4.86%+10.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
N/AN/AN/AN/AN/AN/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/AN/AN/AN/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
0.00
N/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
2.65
Moderate Buy$25.03N/A
INRO
iShares U.S. Industry Rotation Active ETF
2.68
Moderate Buy$27.86N/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
N/AN/AN/AN/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/AN/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$9.67M2.79N/AN/A$3.11 per share3.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
N/AN/A0.00N/AN/AN/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/AN/A31.46N/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/A24.23N/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
-$39.72M-$3.60N/A1,114.79N/A-98.84%-77.30%-37.75%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
$0.050.14%N/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/A0.00%N/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
$0.170.61%N/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/A0.50%N/AN/AN/A

Latest BTGD, FCUS, INRO, and KOOL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/17/2025
INRO
iShares U.S. Industry Rotation Active ETF
$0.04013/18/20253/18/20253/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
N/AN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.50
1.52
0.91
CompanyEmployeesShares OutstandingFree FloatOptionable
STKD Bitcoin & Gold ETF stock logo
BTGD
STKD Bitcoin & Gold ETF
N/A1.03 millionN/AN/A
FCUS
Pinnacle Focused Opportunities ETF
N/A1.38 millionN/ANot Optionable
INRO
iShares U.S. Industry Rotation Active ETF
N/A940,000N/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
532.42 millionN/ANot Optionable

Recent News About These Companies

Stephanie Cesca remembers Western through her next novel
Janssen-Kool Honda
Today is: National Kool-Aid Day
Kool & the Gang Is A Generational Groove
Cesca Explains account managing
Aspiring musician Cesca impresses

New MarketBeat Followers Over Time

Media Sentiment Over Time

STKD Bitcoin & Gold ETF stock logo

STKD Bitcoin & Gold ETF NYSEARCA:BTGD

$36.23 +0.29 (+0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$36.00 -0.23 (-0.63%)
As of 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The STKD Bitcoin & Gold ETF (BTGD) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an actively managed fund that provides combined exposure to Bitcoin and gold through futures contracts and ETPs. The fund uses leverage to stack the total return of its Bitcoin holdings with the potential returns of the gold strategy. BTGD was launched on Oct 15, 2024 and is issued by Stacked.

Pinnacle Focused Opportunities ETF NYSEARCA:FCUS

$25.03 +0.17 (+0.68%)
As of 04:10 PM Eastern

The Pinnacle Focused Opportunities ETF (FCUS) is an exchange-traded fund that is based on the EQM Pinnacle Focused Equity index. The fund is an actively managed fund that toggles between large-cap equities and Treasurys, or a combination of both, based on a proprietary model that identifies positive and negative market signals in the US equity market. FCUS was launched on Dec 29, 2022 and is managed by Pinnacle.

iShares U.S. Industry Rotation Active ETF NASDAQ:INRO

$27.86 +0.15 (+0.54%)
As of 03:55 PM Eastern

The BlackRock U.S. Industry Rotation ETF (INRO) is an exchange-traded fund that mostly invests in total market equity. The fund seeks to provide long-term capital appreciation through an actively managed portfolio of US equities. The portfolio rotates towards industries that BlackRock believes are best positioned for outperformance INRO was launched on Mar 26, 2024 and is issued by BlackRock.

Cesca Therapeutics stock logo

Cesca Therapeutics NASDAQ:KOOL

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.